Envista Holdings
Envista Holdings Corporation is an American medical technology company that develops, manufactures, and markets dental products and equipment globally. The company operates through two primary segments: Specialty Products & Technologies, which encompasses implants, prosthetics, and orthodontics, and Equipment & Consumables, which offers imaging units and consumables. Its portfolio features recognized brands such as Nobel Biocare, Ormco, Dexis, and Kerr, serving dental professionals worldwide. Revenue is derived from direct sales and distributor networks supplying dental consumables, imaging systems, clear aligners, and dental implant systems. Envista holds a leading global position in the dental technology market, serving a broad base of clinicians, specialists, and dental laboratories. The company is headquartered in Brea, California, United States, and its common stock is traded on the New York Stock Exchange.
10 of the funds FundTelligence covers report a position in Envista Holdings.
- Legal name
- Envista Holdings Corp
- Sector
- Health Care
- Country
- United States
- Funds holding it
- 10
Funds holding Envista Holdings
- FTGF Royce US Smaller Companies Fund — Franklin Templeton · 2.74 % (full portfolio disclosed, September 2026)
- JPM US Smaller Companies Fund — JPM · 1.48 % (full portfolio disclosed, June 2026)
- T. Rowe Price US Smaller Companies Equity Fund — T. Rowe Price · 0.46 % (full portfolio disclosed, September 2026)
- Storebrand Global Multifactor — Storebrand · 0.14 % (full portfolio disclosed, October 2026)
- Nordea BetaPlus Enhanced Global Sustainable Small Cap — Nordea Funds · 0.11 % (full portfolio disclosed, September 2026)
- Mercer Global Small Cap Equity Fund — Mercer · 0.04 % (full portfolio disclosed, December 2025)
- DNB Global Enhanced Small Cap — DNB · 0.04 % (full portfolio disclosed, September 2026)
- KLP AksjeGlobal Small Cap Indeks — KLP · 0.04 % (partially disclosed portfolio, June 2026)
Showing the 8 largest of 10 funds holding it.